-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group has been recognized as an Outstanding Lean Management Enterprise in Cangzhou City for 2025.
Category:
发布时间：2025-07-11
【概要描述】
On July 8, the Cangzhou Municipal Bureau of Industry and Information Technology issued the “Notice on Announcing the Outstanding Lean Management Enterprises of Cangzhou for 2025.” Following procedures including enterprise applications, verification and recommendations by counties (cities and districts), tripartite evaluation, centralized deliberation, and public announcement, Hebei Guangxiang Pharmaceutical Co., Ltd. and 12 other enterprises were recognized as Outstanding Lean Management Enterprises of Cangzhou for 2025.
On July 8, the Cangzhou Municipal Bureau of Industry and Information Technology issued the “Notice on Announcing the Outstanding Lean Management Enterprises of Cangzhou City for 2025.” Following procedures including enterprise applications, verification and recommendations by counties (cities and districts), tripartite evaluation, centralized deliberation, and public announcement, Hebei Guangxiang Pharmaceutical Co., Ltd. and 12 other enterprises were recognized as Outstanding Lean Management Enterprises of Cangzhou City for 2025.
In recent years, Guangxiang Pharmaceutical Group has consistently regarded lean management as one of the core strategies for corporate development, striving to comprehensively enhance innovation capability, production efficiency, product quality, and operational management through technological innovation, process optimization, and digital empowerment. Adhering to the guiding principles of “quality first, technology paramount, green and low-carbon practices, and the integration of digital and intelligent technologies,” Guangxiang Pharmaceutical is driven by innovation, continuously intensifying its R&D efforts, establishing national-level and multiple provincial-level high-caliber technology innovation platforms, overcoming a number of critical “bottleneck” technological challenges, and steadily improving the quality and efficiency of bulk and specialty APIs. At the same time, the company integrates the concept of green development into its lean management approach, adopting clean production processes to reduce resource consumption, strengthening dynamic monitoring and management of pollutants, thereby achieving a win-win outcome in both economic and ecological benefits and earning recognition as a national-level green factory.
“By integrating lean management across the entire value chain—research and development, manufacturing, quality control, and operations—since the beginning of this year, our flagship product caffeine has obtained EU CEP certification, and seven new API products, including nicardipine hydrochloride, nimodipine, and felodipine, have been successively approved, marking substantial progress in corporate management and operations,” said the head of Guangxiang Pharmaceutical. “Going forward, we will aim to build a more efficient, agile, and sustainable lean management system, accelerate technological innovation and digital transformation, continuously enhance our core competitiveness, and strive to make greater contributions to the region’s economic and social development.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091